Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
<iframe src="https://statesidedaily.com/embed/cluster/a1bafd42fa28ef4120c3f9a9f875202186b11758" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Intero Biosystems wants drugmakers to test on mini human intestines, not animals"></iframe>
